• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过基于多细胞代理的模型探索前列腺癌的发生和发展。

Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model.

机构信息

Department of Biomedical Engineering, Eindhoven University of Technology, Eindhoven, the Netherlands.

Institute for Complex Molecular Systems, Eindhoven University of Technology, Eindhoven, the Netherlands.

出版信息

Cancer Res Commun. 2023 Aug 7;3(8):1473-1485. doi: 10.1158/2767-9764.CRC-23-0097. eCollection 2023 Aug.

DOI:10.1158/2767-9764.CRC-23-0097
PMID:37554550
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10405859/
Abstract

UNLABELLED

Over 10% of men will be diagnosed with prostate cancer during their lifetime. Arising from luminal cells of the prostatic acinus, prostate cancer is influenced by multiple cells in its microenvironment. To expand our knowledge and explore means to prevent and treat the disease, it is important to understand what drives the onset and early stages of prostate cancer. In this study, we developed an agent-based model of a prostatic acinus including its microenvironment, to allow for studying of prostate cancer development. The model was based on prior reports and in-house data of tumor cells cocultured with cancer-associated fibroblasts (CAF) and protumor and/or antitumor macrophages. Growth patterns depicted by the model were pathologically validated on hematoxylin and eosin slide images of human prostate cancer specimens. We identified that stochasticity of interactions between macrophages and tumor cells at early stages strongly affect tumor development. In addition, we discovered that more systematic deviations in tumor development result from a combinatorial effect of the probability of acquiring mutations and the tumor-promoting abilities of CAFs and macrophages. modeled tumors were then compared with 494 patients with cancer with matching characteristics, showing strong association between predicted tumor load and patients' clinical outcome. Our findings suggest that the likelihood of tumor formation depends on a combination of stochastic events and systematic characteristics. While stochasticity cannot be controlled, information on systematic effects may aid the development of prevention strategies tailored to the molecular characteristics of an individual patient.

SIGNIFICANCE

We developed a computational model to study which factors of the tumor microenvironment drive prostate cancer development, with potential to aid the development of new prevention strategies.

摘要

未加标签

一生中超过 10%的男性将被诊断患有前列腺癌。前列腺癌起源于前列腺腺泡的腔细胞,受其微环境中的多种细胞影响。为了扩展我们的知识并探索预防和治疗这种疾病的方法,了解是什么驱动了前列腺癌的发生和早期阶段非常重要。在这项研究中,我们开发了一个包括其微环境在内的前列腺腺泡的基于代理的模型,以允许研究前列腺癌的发展。该模型基于肿瘤细胞与癌相关成纤维细胞(CAF)以及促肿瘤和/或抗肿瘤巨噬细胞共培养的先前报告和内部数据。模型描绘的生长模式通过人类前列腺癌标本的苏木精和伊红幻灯片图像进行了病理学验证。我们发现,巨噬细胞和肿瘤细胞之间在早期的相互作用的随机性强烈影响肿瘤的发展。此外,我们发现,肿瘤发展的更系统偏差源自获得突变的概率和 CAF 和巨噬细胞的肿瘤促进能力的组合效应。然后将模型肿瘤与 494 名具有匹配特征的癌症患者进行比较,结果显示预测的肿瘤负荷与患者的临床结果之间存在很强的关联。我们的研究结果表明,肿瘤形成的可能性取决于随机事件和系统特征的组合。虽然随机性无法控制,但有关系统效应的信息可能有助于制定针对个体患者分子特征的预防策略。

意义

我们开发了一种计算模型来研究肿瘤微环境中的哪些因素驱动前列腺癌的发展,这可能有助于开发新的预防策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/1c8ac323be69/crc-23-0097_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/6e09b6f2f491/crc-23-0097_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/4432a96d6723/crc-23-0097_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/dba4b80fb0d1/crc-23-0097_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/c52e525cdd56/crc-23-0097_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/6b7278ac215b/crc-23-0097_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/f2941dea3506/crc-23-0097_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/1c8ac323be69/crc-23-0097_fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/6e09b6f2f491/crc-23-0097_fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/4432a96d6723/crc-23-0097_fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/dba4b80fb0d1/crc-23-0097_fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/c52e525cdd56/crc-23-0097_fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/6b7278ac215b/crc-23-0097_fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/f2941dea3506/crc-23-0097_fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8f7/10405859/1c8ac323be69/crc-23-0097_fig7.jpg

相似文献

1
Exploring the Onset and Progression of Prostate Cancer through a Multicellular Agent-based Model.通过基于多细胞代理的模型探索前列腺癌的发生和发展。
Cancer Res Commun. 2023 Aug 7;3(8):1473-1485. doi: 10.1158/2767-9764.CRC-23-0097. eCollection 2023 Aug.
2
Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.基质肿瘤微环境甲基化组的改变预示着前列腺癌的存在和严重程度。
Clin Epigenetics. 2020 Mar 18;12(1):48. doi: 10.1186/s13148-020-00836-2.
3
Tissue engineered human prostate microtissues reveal key role of mast cell-derived tryptase in potentiating cancer-associated fibroblast (CAF)-induced morphometric transition in vitro.组织工程化的人前列腺微组织揭示了肥大细胞衍生的类胰蛋白酶在体外增强癌症相关成纤维细胞(CAF)诱导的形态计量学转变中的关键作用。
Biomaterials. 2019 Mar;197:72-85. doi: 10.1016/j.biomaterials.2018.12.030. Epub 2019 Jan 2.
4
Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment.人前列腺癌相关成纤维细胞的异质性提示其在髓系细胞募集中的亚群作用。
Prostate. 2020 Feb;80(2):173-185. doi: 10.1002/pros.23929. Epub 2019 Nov 25.
5
Novel Therapeutic Targets and Biomarkers Associated with Prostate Cancer-Associated Fibroblasts (CAFs).与前列腺癌相关成纤维细胞(CAFs)相关的新型治疗靶点和生物标志物。
Crit Rev Oncog. 2022;27(1):1-24. doi: 10.1615/CritRevOncog.2022043478.
6
Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.前列腺癌相关成纤维细胞(CAFs)中雄激素受体信号的丧失促进 CCL2 和 CXCL8 介导的癌细胞迁移。
Mol Oncol. 2018 Aug;12(8):1308-1323. doi: 10.1002/1878-0261.12327. Epub 2018 Jul 10.
7
Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF).白藜芦醇对人前列腺癌相关成纤维细胞(CAF)中突变型TRPA1离子通道的激活作用。
Mol Carcinog. 2017 Aug;56(8):1851-1867. doi: 10.1002/mc.22642. Epub 2017 May 22.
8
Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells.激肽释放酶相关肽酶 4可诱导前列腺源性基质细胞呈现癌症相关成纤维细胞特征。
Mol Oncol. 2017 Oct;11(10):1307-1329. doi: 10.1002/1878-0261.12075. Epub 2017 Aug 10.
9
SOX9 in prostate cancer is upregulated by cancer-associated fibroblasts to promote tumor progression through HGF/c-Met-FRA1 signaling.前列腺癌中的 SOX9 通过肿瘤相关成纤维细胞上调,通过 HGF/c-Met-FRA1 信号促进肿瘤进展。
FEBS J. 2021 Sep;288(18):5406-5429. doi: 10.1111/febs.15816. Epub 2021 Apr 2.
10
Structure and Function of a Prostate Cancer Dissemination-Permissive Extracellular Matrix.前列腺癌播散许可性细胞外基质的结构与功能
Clin Cancer Res. 2017 May 1;23(9):2245-2254. doi: 10.1158/1078-0432.CCR-16-1516. Epub 2016 Oct 31.

引用本文的文献

1
Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties.基于主体的前列腺肿瘤微环境建模揭示了空间肿瘤生长限制和免疫调节特性。
NPJ Syst Biol Appl. 2024 Feb 21;10(1):20. doi: 10.1038/s41540-024-00344-6.

本文引用的文献

1
MAST: a hybrid Multi-Agent Spatio-Temporal model of tumor microenvironment informed using a data-driven approach.MAST:一种采用数据驱动方法构建的肿瘤微环境混合多智能体时空模型。
Bioinform Adv. 2022 Dec 5;2(1):vbac092. doi: 10.1093/bioadv/vbac092. eCollection 2022.
2
Agent-based methods facilitate integrative science in cancer.基于主体的方法促进癌症的综合科学。
Trends Cell Biol. 2023 Apr;33(4):300-311. doi: 10.1016/j.tcb.2022.10.006. Epub 2022 Nov 17.
3
PSMA-targeting TGFβ-insensitive armored CAR T cells in metastatic castration-resistant prostate cancer: a phase 1 trial.
PSMA 靶向 TGFβ 不敏感装甲 CAR T 细胞治疗转移性去势抵抗性前列腺癌:一项 1 期试验。
Nat Med. 2022 Apr;28(4):724-734. doi: 10.1038/s41591-022-01726-1. Epub 2022 Mar 21.
4
Molecular mechanisms and genetic alterations in prostate cancer: From diagnosis to targeted therapy.前列腺癌的分子机制与基因改变:从诊断到靶向治疗
Cancer Lett. 2022 May 28;534:215619. doi: 10.1016/j.canlet.2022.215619. Epub 2022 Mar 8.
5
Genetic testing in prostate cancer management: Considerations informing primary care.前列腺癌管理中的基因检测:为初级保健提供信息的考虑因素。
CA Cancer J Clin. 2022 Jul;72(4):360-371. doi: 10.3322/caac.21720. Epub 2022 Feb 24.
6
Macrophages as a Therapeutic Target in Metastatic Prostate Cancer: A Way to Overcome Immunotherapy Resistance?巨噬细胞作为转移性前列腺癌的治疗靶点:克服免疫治疗耐药性的一种方法?
Cancers (Basel). 2022 Jan 16;14(2):440. doi: 10.3390/cancers14020440.
7
Immunotherapy for prostate cancer: Requirements for a successful regime transfer.前列腺癌的免疫疗法:成功转移方案的要求。
Investig Clin Urol. 2022 Jan;63(1):3-13. doi: 10.4111/icu.20210369.
8
Updates on Molecular and Biochemical Development and Progression of Prostate Cancer.前列腺癌分子与生化发展及进展的最新情况
J Clin Med. 2021 Oct 31;10(21):5127. doi: 10.3390/jcm10215127.
9
Single-Cell Analysis Reveals EP4 as a Target for Restoring T-Cell Infiltration and Sensitizing Prostate Cancer to Immunotherapy.单细胞分析揭示 EP4 是恢复 T 细胞浸润和使前列腺癌对免疫治疗敏感的靶点。
Clin Cancer Res. 2022 Feb 1;28(3):552-567. doi: 10.1158/1078-0432.CCR-21-0299. Epub 2021 Nov 5.
10
Interpretable systems biomarkers predict response to immune-checkpoint inhibitors.可解释的系统生物标志物可预测对免疫检查点抑制剂的反应。
Patterns (N Y). 2021 Jun 30;2(8):100293. doi: 10.1016/j.patter.2021.100293. eCollection 2021 Aug 13.